2HRAD Stock Overview

Engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. More details

2HRAD fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	2/6
Financial Health	4/6
Dividends	0/6

Rewards

Trading at 21.5% below our estimate of its fair value

Risk Analysis

Earnings are forecast to decline by an average of 47.8% per year for the next 3 years

Shares are highly illiquid

Profit margins (2.8%) are lower than last year (4.8%)

My Notes

Capture your thoughts, links and company narrative

H&R GmbH & Co. KGaA Competitors

Treatt

LSE:TET

UK£283.1m

Iofina

AIM:IOF

UK£36.0m

Victrex

LSE:VCT

UK£911.6m

Johnson Matthey

LSE:JMAT

UK£2.2b

Price History & Performance

Summary of share price highs, lows and changes for H&R GmbH KGaA
Historical stock prices
Current Share Price	€6.44
52 Week High	€6.54
52 Week Low	€6.44
Beta	1.28
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	32.51%
5 Year Change	-55.11%
Change since IPO	-57.22%

Recent updates

Shareholder Returns

	2HRAD	GB Chemicals	GB Market
7D	0%	-2.0%	0.8%
1Y	n/a	-22.9%	4.4%

Return vs Industry: Insufficient data to determine how 2HRAD performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how 2HRAD performed against the UK Market.

Price Volatility

Is 2HRAD's price volatile compared to industry and market?
2HRAD volatility
2HRAD Average Weekly Movement	n/a
Chemicals Industry Average Movement	5.8%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.6%
10% least volatile stocks in GB Market	2.5%

Stable Share Price: 2HRAD has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 2HRAD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2016	1,657	Niels Hansen	www.hur.com

H&R GmbH & Co. KGaA manufactures and sells chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as feedstocks and bunker fuels.

H&R GmbH & Co. KGaA Fundamentals Summary

How do H&R GmbH KGaA's earnings and revenue compare to its market cap?
2HRAD fundamental statistics
Market cap	€235.99m
Earnings (TTM)	€43.26m
Revenue (TTM)	€1.54b

5.5x

P/E Ratio

0.2x

P/S Ratio

Is 2HRAD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2HRAD income statement (TTM)
Revenue	€1.54b
Cost of Revenue	€1.22b
Gross Profit	€323.82m
Other Expenses	€280.56m
Earnings	€43.26m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	1.16
Gross Margin	21.03%
Net Profit Margin	2.81%
Debt/Equity Ratio	42.2%

How did 2HRAD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/12/11 11:45
End of Day Share Price	2022/09/13 00:00
Earnings	2022/09/30
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

H&R GmbH & Co. KGaA is covered by 15 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Konstantin Wiechert	Baader Helvea Equity Research
Knut Woller	Baader Helvea Equity Research
Heiko Feber	Bankhaus Lampe KG

H&R GmbH KGaA BATS-CHIXE:2HRAD Stock Report